Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer

被引：46
|
作者：
Helm, C. William [1 ]
机构：
[1] St Louis Univ, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, St Louis, MO 63117 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2012年 / 21卷 / 04期
关键词：
Ovarian cancer; Epithelial ovarian cancer; Intraperitoneal chemotherapy; HIPEC; Hyperthermia; Hyperthermic intraperitoneal chemotherapy; GYNECOLOGIC-ONCOLOGY-GROUP; PEGYLATED LIPOSOMAL DOXORUBICIN; LONG-TERM SURVIVAL; DNA DAMAGE RESPONSES; PHASE-II TRIAL; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY; STAGE-III; FOLLOW-UP; SECONDARY CYTOREDUCTION;
D O I：
10.1016/j.soc.2012.07.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epithelial ovarian cancer is a peritoneal surface malignancy that most often presents with spread of disease within the peritoneal cavity. Overall 5-year survival is around 50% and progress in improving outcomes is slow. Among other areas of research, hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising option. This article reviews the current status of treatment of epithelial ovarian cancer, experience with HIPEC to date, and future directions.
引用
收藏
页码：645 / +
页数：20
相关论文
共 50 条
  • [1] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer
    Polom, Karol
    Roviello, Giandomenico
    Generali, Daniele
    Marano, Luigi
    Petrioli, Roberto
    Marsili, Stefania
    Caputo, Edda
    Marrelli, Daniele
    Roviello, Franco
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (03) : 298 - 310
  • [2] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
    Schmalfeldt, Barbara
    [J]. CHIRURGIE, 2022, 93 (12): : 1144 - 1151
  • [3] The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse
    Saladino E.
    Fleres F.
    Irato S.
    Famulari C.
    Macrì A.
    [J]. Updates in Surgery, 2014, 66 (2) : 109 - 113
  • [4] Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
    al-Shammaa, Hassan Alaa Hammed
    Li, Yan
    Yonemura, Yutaka
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (08) : 1159 - 1166
  • [5] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: opportunity and obligations
    Miner, Thomas J.
    [J]. 13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 37 - 39
  • [6] Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
    Hassan Alaa Hammed al-Shammaa
    Yutaka Yonemura
    [J]. World Journal of Gastroenterology, 2008, (08) : 1159 - 1166
  • [7] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    Helm, C. William
    Bristow, Robert E.
    Kusamura, Shigeki
    Baratti, Dario
    Deraco, Marcello
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
  • [8] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: World experience
    Helm, C. William
    [J]. Intraperitoneal Cancer Therapy, 2007, : 147 - 161
  • [9] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: Experience in France
    Glehen, Olivier
    Gilly, Francois-Noel
    [J]. INTRAPERITONEAL CANCER THERAPY, 2007, : 131 - +
  • [10] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer
    Classe, Jean-Marc
    Glehen, Olivier
    Decullier, Evelyne
    Bereder, Jean Marc
    Msika, Simon
    Lorimier, Gerard
    Abboud, Karine
    Meeus, Pierre
    Ferron, Gwenael
    Quenet, Francois
    Marchal, Frederic
    Gouy, Sebastien
    Pomel, Christophe
    Pocard, Marc
    Guyon, Frederic
    Bakrin, Naoual
    [J]. ANTICANCER RESEARCH, 2015, 35 (09) : 4997 - 5005
12345